The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
Failed Pfizer-Allergan Deal: Other Mergers Affected?
Posted
April 7, 2016
Views
2,821
Likes
23
Engagement
0.82%
April 7, 2016
2,821
23
0.82%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:36Now PlayingPfizer and Allergan terminated their $150 billion proposed merger after the Obama Administration took aim at corporate inversion deals. WSJ's Liz Hoffman joins Lunch Break with Tanya Rivero and explains how the termination potentially affects future corporate mergers. Photo: Reuters
Subscribe to the WSJ channel here:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
